Both in Lab Analytical Instruments
Harvard Bioscience vs Rapid Micro Biosystems
Over the past year HBIO returned +72.3% and RPID returned −75.4%; their daily moves had a correlation of -0.19.
HBIO +72.3% RPID −75.4%Growth of $1, one year, split-adjusted
| Metric | HBIO | RPID |
|---|---|---|
| Price | $8.90 | $0.7359 |
| Market cap | $40.5M | $36.9M |
| Today | +1.14% | −6.73% |
| 1 month | +9.5% | −20.1% |
| 6 months | +39.9% | −70.9% |
| Year to date | +33.1% | −74.6% |
| 1 year | +99.3% | −74.4% |
| Revenue growth (YoY) | +11.1% | +10.9% |
| Gross margin | 55.6% | 15.0% |
| Net margin | −12.8% | −160.5% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 1.0× |
| Net cash | -$30.2M | $627.0K |
| Dividend yield | — | — |
| Volatility (60d) | 36.4% | 66.5% |
| Short % of float | 1.5% | 3.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).